KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 75 filers reported holding KALA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.12 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $26,000 | -50.0% | 9,750 | 0.0% | 0.01% | -41.7% |
| Q2 2021 | $52,000 | +44.4% | 9,750 | +80.7% | 0.01% | +50.0% |
| Q1 2021 | $36,000 | -43.8% | 5,397 | -42.7% | 0.01% | -50.0% |
| Q4 2020 | $64,000 | +33.3% | 9,415 | +46.8% | 0.02% | +23.1% |
| Q3 2020 | $48,000 | +6.7% | 6,415 | +50.7% | 0.01% | 0.0% |
| Q2 2020 | $45,000 | -54.5% | 4,256 | -62.2% | 0.01% | -64.9% |
| Q1 2020 | $99,000 | +350.0% | 11,250 | +150.0% | 0.04% | +236.4% |
| Q4 2018 | $22,000 | – | 4,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vahanian & Associates Financial Planning Inc. | 1,046,484 | $1,266,000 | 1.02% |
| RA Capital Management | 10,874,613 | $13,158,000 | 0.23% |
| Samsara BioCapital, LLC | 601,162 | $727,000 | 0.14% |
| Matisse Capital | 41,400 | $50,000 | 0.04% |
| Manteio Capital LLC | 19,546 | $24,000 | 0.03% |
| Covestor Ltd | 17,766 | $21,000 | 0.03% |
| Knights of Columbus Asset Advisors LLC | 241,857 | $293,000 | 0.02% |
| Virtu Financial LLC | 126,231 | $153,000 | 0.02% |
| Aquatic Capital Management LLC | 6,200 | $8,000 | 0.02% |
| CAXTON CORP | 13,155 | $16,000 | 0.01% |